The oral NLRP3 inhibitor used in the study (Dapansutrile) has already shown to be effective in clinical trials to treat gout and heart disease, and it is currently being tested in Covid-19 as well.
April 9, 2021Risk of oral clefts is most pronounced in women taking higher doses of topiramate to treat epilepsy.
December 30, 2017